Christoph Renner

Klinik Hirslanden — Switzerland

Immunology and Microbiology · Life Sciences

44h-index6.9kcitations252works0.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(60), Monoclonal and Polyclonal Antibodies Research(58), Lymphoma Diagnosis and Treatment(43), CAR-T cell therapy research(39), Immune Cell Function and Interaction(34)

Publications251 total

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland
Swiss Medical Weekly·2025Open Access
1542P IOS-1002, a first-in-class multi-checkpoint inhibitor, shows encouraging clinical activity in combination with pembrolizumab in advanced solid tumors
Annals of Oncology·2025
273 | REAL‐WORLD OUTCOMES OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: A MULTICENTER ANALYSIS WITH A CONTROL COHORT FROM THE EUROPEAN MCL REGISTRY
Hematological Oncology·2025Open Access
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data
Swiss Medical Weekly·2024· 1 citedOpen Access
Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology
Acta Dermato Venereologica·2024Open Access
IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity
Cancers·2024· 2 citedOpen Access
Review for "The complement system as a target in cancer immunotherapy"
2024
Review for "The complement system as a target in cancer immunotherapy"
2024
Notfälle in der Onkologie
2024
Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997–2021
Hematological Oncology·2023· 2 citedOpen Access
A National Platform and Scoring System Allocates CAR-T Treatment Slots for Multiple Myeloma to Patients with High Likelihood of Complete Remission
Blood·2023· 2 cited
714TiP A phase Ia/Ib, first-in-human, dose-escalation study evaluating the safety, tolerability, and efficacy of IOS-1002, a LILRB1, LILRB2, and KIR3DL1 targeting HLA-derived fusion protein administered alone or in combination with a PD-1 antibody in patients with advanced solid tumors
Annals of Oncology·2023Open Access
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)
EClinicalMedicine·2023· 11 citedOpen Access
Vortex-core spectroscopy of $d$-wave cuprate high-temperature superconductors
arXiv (Cornell University)·2023Open Access
Twist angle dependent electronic properties of exfoliated single layer MoS$_2$ on Au(111)
arXiv (Cornell University)·2023· 1 citedOpen Access
Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study.
Journal of Clinical Oncology·2023· 1 cited
Figure S6 from Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
2023Open Access
supplementary notes from Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
2023Open Access
Data from Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
2023Open Access
Data from Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Michael Pfreundschuh(11), Stefan Bauer(11), Andreas Wadle(9), Ulf Petrausch(8), Gerhard Held(7), Axel Mischo(7), Alexander Knuth(7), Frank Stenner(6), Andrew M. Scott(6), Petra Schuberth(5), Panagiotis Samaras(5), Sascha Kleber(4), Jochen Imig(4), Wolfram Jung(4), Marianne Tinguely(4), Gerd Ritter(4), Lloyd J. Old(4), Volker Diehl(3), Shawn M. Jensen(3), Alex Soltermann(3)